In contrast, another study found serum levels of CTRP9 were higher in patients with obesity-associated comorbidities (e.g., diabetes, hypertension, hypercholesterolemia) than healthy normal-weight individuals, but following weight-loss surgery there was decrease in CTRP9 [14]. Here, C1QTNF9 is linked to Hypercholesterolemia.